Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-01 · accession 0001193125-25-230420 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-01 | NTLA | Dube Michael P | VP, CAO | S - Sale | $17.38 | -1,871 | 55.3K | -3% | -$32.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-01 | S | D | 1,871 | $17.38 | 55,266 | D | — | — |